Imicarp

Imicarp is a veterinarian-prescribed injectable solution formulated to prevent and treat babesiosis and anaplasmosis in racing horses, camels, and other susceptible animals. It targets a broad spectrum of blood-borne protozoan parasites, ensuring effective disease control and improved animal health.

Active Spectrum:

• Babesia bovis, Babesia bigemina (cattle)

• Anaplasma marginale (cattle)

• Babesia ovis (sheep)

• Babesia caballi, Babesia equi (horses, donkeys, mules)

• Babesia canis (dogs)

Key Benefits:

• Broad-spectrum protozoal protection

• Treats active infections and prevents new cases

• Adaptable administration: intramuscular or subcutaneous

• Supports racing animal health and performance

Dosage and Administration:

• Dose varies by species, weight, and treatment purpose

• Administered via IM or SC injection

• Always follow veterinarian’s prescribed dosage and schedule

Broad-spectrum antiparasitic action

Effective in multiple animal species

Long-lasting prophylactic protection

Precise dosing for small animals

Flexible intramuscular or subcutaneous use

Imicarp Injectable Solution contains 120 mg of imidocarb dipropionate, equivalent to 85 mg of imidocarb.